Inactive Instrument
Quotes Cardium Therapeutics Inc NYSE
Stocks
CXM
US1419163043
Biotechnology & Medical Research
|
End-of-day quote
NYSE
|
||
| - USD | - |
|
| 22-03-29 | Gene Biotherapeutics, Inc. Auditor Raises 'Going Concern' Doubt | CI |
| 21-09-03 | Gene Biotherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2020 | CI |
Stock exchange
NYSE
CXM - $
-
0
$
| Markets | Price | Change | Volumes |
|---|
Basic data
Market Cap (USD)
64
Free-Float
93.84 %
Free-Float capitalization (USD)
60
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | 0.00% | - | - | 64 | |
| -1.23% | -1.91% | +0.98% | +17.94% | 50.47B | |
| -1.11% | -2.84% | +420.04% | +505.15% | 44.56B | |
| -0.21% | +0.37% | +36.88% | +17.32% | 43.08B | |
| -1.95% | -3.33% | +8.29% | +73.25% | 41.7B | |
| -0.94% | -1.77% | +18.34% | +46.84% | 33.21B | |
| -1.11% | -4.20% | +25.49% | +119.78% | 16.77B | |
| +6.10% | +4.40% | - | - | 16.28B | |
| +0.25% | -0.98% | +11.91% | +27.62% | 14.58B | |
| -1.12% | -3.46% | +76.50% | +39.37% | 13.92B | |
| Average | -0.15% | -1.79% | +74.80% | +105.91% | 27.46B | |
| Weighted average by Cap. | -0.60% | -1.57% | +88.95% | +122.85% |
Historical Quotes: Cardium Therapeutics Inc
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Price Extremes
- Stock Market
- Stocks
- CRXM Stock
- CXM Stock
- Quotes Cardium Therapeutics Inc
Select your edition
All financial news and data tailored to specific country editions
